Specialized Clinical Trials
Our researchers and medical doctors are collaborating with scientists and physicians all over the world who are working to find better treatment options, and ultimately a cure, for brain cancer. Some of the most exciting trials are being hosted right here at the Preston A. Wells Jr. Center for Brain Tumor Therapy, including several trials that are being implemented for people for the first time. Some of the most unique trials in the world are being led by researchers and doctors here on our campus.
Pediatrics
- ACTION: Adoptive Cellular Therapy following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas
- BRAVO: Newly-Diagnosed Brain Stem Gliomas Treated with Adoptive Cellular Therapy during Recovery from Focal Radiotherapy Alone or Radiotherapy and Dose-intensified Temozolomide
- PEACH: Precision mEdicine and Adoptive Cellular tHerapy for the treatment of recurrent neuroblastoma and newly diagnosed diffuse intrinsic pontine glioma (DIPG)
Contact Marcia Hodik, RN, at (352) 273-8742 or marcia.hodik@neurosurgery.ufl.edu.
Adults
- ASPIRE: RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
- ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Contact Phuong Deleyrolle, RN, at (352) 273-5529 or phuong.deleyrolle@neurosurgery.ufl.edu.
- PNOC020: RNA-Lipid Particle Vaccines for Adult GBM
Contact Marcia Hodik, RN, at (352) 273-8742 or marcia.hodik@neurosurgery.ufl.edu.